Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqGM - Nasdaq Real Time Price • USD Anbio Biotechnology Class A Ordinary Shares (NNNN) Follow Compare 5.77 +0.10 +(1.76%) At close: February 21 at 4:00:01 PM EST 5.77 0.00 (0.00%) After hours: February 21 at 7:52:57 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Undiscovered Gems In The US Featuring Anbio Biotechnology And 2 Other Small Caps The United States market has remained flat over the past week but has shown a robust 21% increase over the last year, with earnings projected to grow by 14% annually. In this dynamic environment, identifying small-cap stocks like Anbio Biotechnology that possess strong growth potential and innovative capabilities can offer intriguing opportunities for investors seeking to uncover lesser-known gems. Anbio Biotechnology Announces Closing of Initial Public Offering Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products, today announced the closing of its initial public offering (the “Offering”) of 1,600,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of US$5.00 per Class A Ordinary Share. The Class A Ordinary Shares began trading on the Anbio Biotechnology Announces Pricing of Initial Public Offering Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products, today announced the pricing of its initial public offering (the “Offering”) of 1,600,000 Class A ordinary shares (“the Class A Ordinary Shares”) at a public offering price of US$5.00 per Class A Ordinary Share. The Class A Ordinary Shares have been approved f Performance Overview Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return NNNN S&P 500 YTD +9.70% +2.24% 1-Year +9.70% +20.70% 3-Year +9.70% +38.27%